Popular Keywords


Bladder cancer

Blood cancer

Bone cancer

Brain cancer


The Toxicities of Laundry Products in the Home: A Review and Commentary on Environmental Oncology

Correspondence to Author:  Constantine Kaniklidis, 

Director, Medical Research, No Surrender Breast Cancer Foundation (NSBCF).


This review of the aggregated data to date finds the overwhelming weight of the evidence supports the contention that many laundry products, via contained ingredients and byproducts such as phthalates, plasticizers, bisphenols, polybrominated diphenyl ethers (PBDEs), polycyclic aromatic hydrocarbons (PAHs), phenols, per-and polyfluoroalkyl substances (PFAS) known as “forever chemicals”, and the contaminant 1,4-dioxane, add significant elevated risk to humans in the reproductive/fertility; respiratory/pulmonary (asthma, cardiopulmonary disease); neurological/cognitive (ADHD, autism); metabolic (diabetes, obesity); and oncogenic (cancer) domains of human health. We focus discussion on the toxicity of these laundry products, the subject of much research and regulatory scrutiny, in order to provide a new understanding of the current state-of-the-art in environmental oncology as it concerns these toxins. We also provide a summary of existing and emerging legislation to regulate and thereby limit the potential multifaceted harms of these products. Concerns have been sufficiently serious and well evidenced that most of these toxic chemicals have been banned in the EU and dozens of nations, with pending prohibitions in over a dozen states in the U.S., and with major retailers now pledging for their elimination from cosmetics, personal care and household products in the near future. But as both a corrective, and a motivation, we also document some of the regulatory resistance and inertia that regrettably impedes more aggressive action.


Constantine Kaniklidis. The Toxicities of Laundry Products in the Home: A Review and Commentary on Environmental Oncology. World Journal of Clinical Cancer Research 2024.

Journal Info

  • Journal Name: World Journal of Clinical Cancer Research
  • Impact Factor: 2.0
  • ISSN: 2831-3275
  • DOI: 10.52338/Wjccr
  • Short Name: WJCCR
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days


  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal


  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility